Showing results (351-360 of 384) with videos related to
Sort By:
Pageof 39
Journal of Cardiovascular Electrophysiology|July 23, 2019
Pressure-guided second-generation cryoballoon pulmonary vein isolation: Prospective comparison of the procedural and clinical outcomes with the conventional strategyKanae Hasegawa, Shinsuke Miyazaki, Kenichi Kaseno, et al.Trials|May 9, 2020
Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, et al.Journal of the American Heart Association|August 10, 2016
Long-Term Prognosis of Brugada-Type ECG and ECG With Atypical ST-Segment Elevation in the Right Precordial Leads Over 20 Years: Results From the Circulatory Risk in Communities Study (CIRCS)Hidekazu Tsuneoka, Masahiko Takagi, Nobuyuki Murakoshi, et al.Trials|June 10, 2020
Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, et al.Breast Cancer (Tokyo, Japan)|June 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancerTsuguo Iwatani, Norikazu Masuda, Shigehira Saji, et al.Breast Cancer Research and Treatment|July 8, 2026
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALDNorikazu Masuda, Shigehira Saji, Yasuyuki Kojima, et al.Heart and Vessels|January 28, 2021
Discrepancy between CARTO and Rhythmia maps for defining the left atrial low-voltage areas in atrial fibrillation ablationKenichi Kaseno, Kanae Hasegawa, Shinsuke Miyazaki, et al.NPJ Breast Cancer|June 26, 2026
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTETatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, et al.Cancer Medicine|October 17, 2022
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational studyHidekazu Shirota, Keigo Komine, Masanobu Takahashi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 11, 2010
Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablationEiji Yamashita, Hiroto Takamatsu, Hiroshi Tada, et al.Pageof 39